NCT05093348

Brief Summary

To undertake a randomised crossover trial in human subjects the Click2Print ocular prosthesis versus an analogue ocular prosthesis demonstrating non-inferiority in the assessment of ocular prosthesis motility, cosmesis, fit and function, comfort, mucous discharge and benefits of use in daily life in 40 data subjects (Crossover Trial).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 26, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

November 25, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 16, 2023

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

1.6 years

First QC Date

August 11, 2021

Last Update Submit

November 28, 2023

Conditions

Keywords

EnucleatedArtificial eyeProsthesisEviscerated

Outcome Measures

Primary Outcomes (1)

  • Comparison of prosthesis motility utilising an excursion assessment to prove non-inferiority of the digital ocular prosthesis

    Each subject will use two different ocular prostheses for an extended period of time and the motility of each will be compared. Each ocular prosthesis will be worn for 4 months. Motility will be assessed at the beginning and after 3 month period of wear for each prosthesis. Motility will be measured by assessing the ocular prosthesis excursion in four angles of gaze. The distance from straight ahead gaze compared to left, right, up and down gaze will be measured in millimetres and recorded on the case report form. These measurements will then be used to compute a total motility score. The data subject will cross-over to wearing the comparator type prosthesis and the motility assessment will be repeated at the beginning and after three month period. The total motility scores of type 1 and type 2 prostheses will then be compared to determine if the digital ocular prosthesis motility is non-inferior to the gold-standard handmade prosthesis.

    8 months

Study Arms (2)

Click2Print digital Artificial Eye

ACTIVE COMPARATOR

Supply and fit a digitally designed and manufactured ocular prosthesis for four months in comparison to the current hand-made ocular prosthesis in a cross over trial

Device: Click2Print artificial eye

Current hand made artificial eye

ACTIVE COMPARATOR

Wear the hand-made artificial eye for four months and compare to the digitally design ed and manufactured artificial eye

Device: Hand-made artificial eye

Interventions

Digitally designed and manufactured ocular prosthesis

Click2Print digital Artificial Eye

Hand-made artificial eye

Current hand made artificial eye

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years and over
  • Adults with surgery to remove one eye with at least 1-year follow-up
  • Able to give consent and understand the study
  • Able to cooperate by following instructions

You may not qualify if:

  • \- Adults with surgery to remove one eye with less than 1-year follow-up.
  • Concurrent socket pathology (Socket infection or exposure).
  • Giant papillary conjunctivitis.
  • Presence of ocular motility disorders on either side of the face, muscle restrictive disorders, previous trauma, idiopathic orbital inflammatory disease and neurological disorders (cranial neuropathies, multiple sclerosis).
  • Data subjects unable to understand the study and unable to give informed consent.
  • Data subjects considered vulnerable.
  • Ongoing participation in another clinical study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moorfields Eye Hospital NHS Foundation Trust, 162 City Road

London, EC1V 2PD, United Kingdom

Location

Study Officials

  • Mandeep Sagoo

    Moorfields Eye Hospital NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Demographics will be such that the data subject cannot be identified. It will not be possible to mask the ocularist, data manager or the trial manager. Every effort will be made to mask the patient and investigators from knowing which type of prosthesis is being worn during the trial. However, due to the differing methods of manufacture of a digital artificial eye compared to the traditional artificial eye, upon close inspection, it may be possible to denote differences in the cosmetic appearance. Should the participant ask or comment on which type of artificial eye they are wearing to the ocularist or research member then a scripted response will be provided. The trial statistician who is analysing trial data will be masked until primary analysis is completed. Un-masking of the ocular prosthesis will occur after confirmation of primary analysis has been performed.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Pseudonymised single site investigation randomised crossover trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2021

First Posted

October 26, 2021

Study Start

November 25, 2021

Primary Completion

July 16, 2023

Study Completion

July 16, 2023

Last Updated

November 30, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

All participant data will remain within the sponsor organisation

Locations